Search results for "reactions"

showing 10 items of 631 documents

Additive effect of factors related to assisted conception on the reduction of maternal serum pregnancy-associated plasma protein A concentrations and…

2013

Objective To analyze whether assisted conceptions need adjustments in first-trimester Down syndrome screening and why modifications in screening markers occur. Design Eleven-year cohort retrospective analysis. Setting Maternal-fetal medicine unit. Patient(s) Two thousand eleven naturally conceived normal singleton pregnancies and 2,042 normal singleton pregnancies achieved with assisted conception: 350 by IUI and 1,692 with IVF (n = 328) or intracytoplasmic sperm injection (ICSI; n=1,364), using nondonor (n = 1,086) or donated ova (n = 606), with fresh (n = 1,432) or frozen (n = 260) embryos. Intervention(s) Comparison of ultrasound and biochemical markers of first-trimester Down syndrome s…

medicine.medical_specialtyPregnancy-associated plasma protein AReproductive Techniques Assistedmedicine.medical_treatmentDown-RegulationFertilization in VitroIntracytoplasmic sperm injectionEmbryo cryopreservationPredictive Value of TestsPregnancyPrenatal DiagnosismedicineHumansPregnancy-Associated Plasma Protein-AChorionic Gonadotropin beta Subunit HumanFalse Positive Reactionsreproductive and urinary physiologyInsemination ArtificialRetrospective StudiesGynecologyDown syndrome screeningAnalysis of VarianceChi-Square DistributionOocyte Donationbusiness.industrySingletonFree βhcgObstetrics and GynecologyPregnancy Trimester FirstReproductive MedicineCohortFemaleHormone therapyDown SyndromebusinessNuchal Translucency MeasurementBiomarkersFertility and sterility
researchProduct

Search for autoantibodies to the human bradykinin B2 receptor.

1997

medicine.medical_specialtyReceptor Bradykinin B2Blotting WesternMolecular Sequence DataEnzyme-Linked Immunosorbent AssayAntigen-Antibody ComplexCross ReactionsChromatography AffinityCohort StudiesHypertension MalignantAdjuvants ImmunologicInternal medicineMedicineAnimalsHumansAmino Acid SequenceBradykinin receptorAntigensAutoantibodiesPharmacologyBinding Sitesbusiness.industryReceptors BradykininAutoantibodyPrecipitin TestsRecombinant ProteinsEndocrinologyImmunoglobulin GHemocyaninsFemaleRabbitsbusinessPeptidesBradykinin B2 ReceptorBaculoviridaeImmunopharmacology
researchProduct

Cross-reactivity of anti-ssDNA antibodies with heparan sulfate in patients with type I diabetes mellitus

1989

Anti-single-stranded–DNA antibodies cross-reactive with heparan sulfate were detected in serums of patients with type I (insulin-dependent) diabetes mellitus. The results suggested that heparan sulfate, the major glycosaminoglycan constituent of the glomerular basement membrane, may serve as a target antigen in vivo for cross-reactive anti-DNA antibodies. These polyreactive antibodies, directed toward repeating negatively charged units, may neutralize the heparan sulfate–associated polyanionic sites in the glomerulus, leading to an abnormal permeability of anionic plasma proteins.

medicine.medical_specialtyRenal glomerulusEndocrinology Diabetes and MetabolismDNA Single-StrandedEnzyme-Linked Immunosorbent AssayPerlecanCross ReactionsBiologyGlycosaminoglycanchemistry.chemical_compoundInternal medicinemedicineInternal MedicineHumansChildGlycosaminoglycansBasement membraneGlomerular basement membraneHeparan sulfateBlood proteinsMolecular biologyDiabetes Mellitus Type 1Endocrinologymedicine.anatomical_structurechemistryImmunoglobulin Gbiology.proteinHeparitin SulfateAntibody
researchProduct

Responses to self and non-self intestinal microflora in health and inflammatory bowel disease.

1997

medicine.medical_specialtyT-LymphocytesImmunologyBiologyCross ReactionsInflammatory bowel diseaseGastroenterologyAntibodiesImmune tolerancePathogenesisMiceImmune systemCrohn DiseaseInternal medicinemedicineAnimalsHumansCrohn diseaseCross reactionsmedicine.diseaseInflammatory Bowel DiseasesUlcerative colitisInterleukin-12Interleukin-10IntestinesInterleukin 10Disease Models AnimalImmunologyForecastingResearch in immunology
researchProduct

Diagnostic efficacy of the fluorometric determination of enzyme activity for Pompe disease from dried blood specimens compared with lymphocytes-possi…

2009

Pompe disease is a rare, autosomal-recessive disorder which results from a defect in the lysosomal enzyme acid alpha-glucosidase (GAA). The onset of this disease is highly variable, with infantile types being the most severe. Traditionally, lymphocytes, fibroblasts or muscle biopsies were necessary for enzyme activity measurement, because these materials do not express maltase-glucoamylase (MGA) that interferes with the assay. Recently, acarbose was found to inhibit MGA activity selectively, so that dried blood became accessible for GAA assessment.To evaluate the diagnostic efficacy of GAA measurement in dried blood specimens (DBSs) in comparison with lymphocytes. If DBSs provided reliable …

medicine.medical_specialtyTime FactorsLymphocyteBiopsyNeonatal ScreeningInternal medicineBiopsyGeneticsmedicineHumansFalse Positive ReactionsFluorometryLymphocytesGenetics (clinical)Acarbosechemistry.chemical_classificationNewborn screeningmedicine.diagnostic_testbiologybusiness.industryGlycogen Storage Disease Type IIMusclesInfant NewbornReproducibility of Resultsalpha-GlucosidasesEnzyme replacement therapyFibroblastsHydrogen-Ion ConcentrationEnzyme assaymedicine.anatomical_structureEndocrinologyEnzymechemistryCarbohydrate Metabolism Disorderbiology.proteinFeasibility Studiesbusinessmedicine.drugJournal of inherited metabolic disease
researchProduct

Cutaneous Adverse Reactions to Highly Antiretroviral Therapy in HIV-Positive Patients

2013

Adverse drug reactions to highly antiretroviral therapy (HAART) are major obstacles in its success. Although overall mortality from HIV has dramatically declined owing to HAART, these antiretroviral regimens have been associated with a wide spectrum of severe cutaneous reactions. The severity of cutaneous adverse reactions varies greatly, and some may be difficult to manage. To optimize adherence and efficacy of antiretroviral treatment, clinicians must focus on preventing adverse effects whenever possible, and distinguish those that are self-limited from those that are potentially serious. This paper presents the case of a serious cutaneous adverse reaction to Atripla in a HIV-positive 50-…

medicine.medical_specialtybusiness.industryHuman immunodeficiency virus (HIV)Adverse drug reactionAdverse drug reactionsHIVDermatologylcsh:RL1-803medicine.disease_causeAntiretroviral therapyPublished online: May 2014Surgerylcsh:DermatologymedicineAntiretroviral treatmentSettore MED/35 - Malattie Cutanee E VenereeDrug reactionIntensive care medicinebusinessAdverse effectHighly antiretroviral therapySkin
researchProduct

Perfluoroalkylated amphiphilic MUC1 glycopeptide antigens as tools for cancer immunotherapy.

2010

The synthesis of perfluoroalkylated glycopeptide antigens and their specific binding to anti-MUC1 mouse antibodies is reported.

medicine.medical_treatmentdigestive systemCatalysisAntibodiesAntigen-Antibody ReactionsMiceAntigenCancer immunotherapyNeoplasmsAmphiphileMaterials ChemistrymedicineAnimalsAntigensskin and connective tissue diseasesneoplasmsMUC1Mice Inbred BALB CBinding SitesbiologyMolecular StructureChemistryMucin-1Metals and AlloysGlycopeptidesGeneral Chemistrybiological factorsdigestive system diseasesGlycopeptideSurfaces Coatings and FilmsElectronic Optical and Magnetic MaterialsBiochemistryCeramics and Compositesbiology.proteinImmunotherapyAntibodyChemical communications (Cambridge, England)
researchProduct

Gas-phase ion chemistry of protonated melatonin

2005

The gas-phase ion chemistry of protonated melatonin has been investigated by mass spectrometric (MS) techniques involving chemical ionisation, fast atom bombardment and electrospray ionisation. Either naturally- occurring or collision-induced decomposition e-D derivatives obtained by exchange with D(2)O. The analysis of experimental results allows definite pathways for the formation of the ion at m/z 174 to be assigned and sheds some more light on the overall fragmentation pathways. Experiments on labelled derivatives evidenced H-D scrambling processes during fragmentation

melatonin ESI/MS ESI/MS/MS deuterium labelled compounds ion chemistry scrambling reactions proton affinitySettore CHIM/02 - Chimica Fisica
researchProduct

Evidence of Partial Seniority Conservation in the pi g9/2 Shell for the N=50 Isotones

2022

The reduced transition probabilities for the 4-> and 2->0 transitions in 92Mo and 94Ru and for the 4->2 and 6->4 transitions in 90Zr have been determined in this experiment making use of a multinucleon transfer reaction. These results have been interpreted on the basis of realistic shell-model calculations in the f5/2, p3/2, p1/2, and g9/2 proton valence space. Only the combination of extensive lifetime information and large scale shell-model calculations allowed the extent of the seniority conservation in the N=50 g9/2 orbital to be understood. The conclusion is that seniority is largely conserved in the first πg9/2 orbital.

multinucleon transfer reactions life-time measurement seniority schemePhysics
researchProduct

Practical Considerations for the Daratumumab Management in Portuguese Routine Clinical Practice: Recommendations From an Expert Panel of Hematologists

2022

The recent therapeutic progress in multiple myeloma (MM) has led to the introduction of novel and highly potent drug classes. Daratumumab was the first CD38-targeting antibody showing to be effective and safe in MM patients as monotherapy and in combination regimens, which led to its rapid implementation in clinical practice. Considering that treatment discontinuation for drug-related adverse events can impact patients’ quality of life and outcomes, the treatment decision should consider different factors and be weighted for each patient individually. Here, we aimed to guide clinicians using daratumumab treatment for MM by addressing practical real-world considerations based on an expert pa…

multiple myelomaCancer ResearchOncologydelivery of health careNeoplasms. Tumors. Oncology. Including cancer and carcinogensadverse reactionsdaratumumabdrug-related side effectsRC254-282Frontiers in Oncology
researchProduct